Titlebook: Neonatal Transfusion Practices; Deborah A. Sesok-Pizzini Book 2017 Springer International Publishing Switzerland 2017 Hemolytic Disease.Hy

Parabola

Blood Product Administration,sed patient groups. Because of advances in neonatal intensive care, including advances in blood component administration, smaller and more premature infants are surviving. This chapter discusses blood components and their suggested indications for transfusion in neonates and reviews vascular access,

Corral

Special Disease Considerations in the Neonate,s in neonates varies from fairly common (anemia) to rare (coagulopathy and polycythemia), but understanding both the differences in reference ranges for neonates and the common causes is important to help guide transfusion practice. A basic definition of each of the hematologic problems from neonata

cipher

Hemolytic Disease of the Fetus and Newborn,roduce this condition are broadly categorized as isoimmune (antibody mediated) or non-isoimmune. While Rh isoimmunization has historically been the most common diagnosis associated with HDFN, the appropriate use of Rh immunoglobulin (RhIG) during pregnancy and just after delivery has made it much le

Osteoporosis

Intrauterine Transfusions,rtality and morbidity. Ultrasound-guided intrauterine transfusion (IUT) is now considered to be the most successful therapy for fetal anemia secondary to red cell alloimmunization. As a result of a cumulative clinical experience, IUT has been expanded to apply as a therapy for multiple fetal indicat

Resign

矛盾

联想

Book 2017dedicated to pre transfusion testing, manufacturing, standards and storage; blood product administration; special congenital and acquired disorders in the neonate; hemolytic disease of the newborn; intrauterine transfusions; adverse reactions; and ECMO. The volume features contributions from a diver

FOLLY

Blood Product Administration,nfants are surviving. This chapter discusses blood components and their suggested indications for transfusion in neonates and reviews vascular access, blood product filters, and warmers. This chapter also presents the use of antifibrinolytics and perioperative transfusion monitoring in neonates.

WAG

Intrauterine Transfusions, to red cell alloimmunization. As a result of a cumulative clinical experience, IUT has been expanded to apply as a therapy for multiple fetal indications including parvovirus B19 infection, fetomaternal hemorrhage, and placental chorioangiomas. Current indications, complications, and long-term outcomes of IUT therapy will be discussed.

敬礼

Special Disease Considerations in the Neonate,l anemia to coagulopathy is presented as well as a brief description of common mechanisms of pathophysiology and guidelines for transfusion practice. Particular attention is directed to fetal/neonatal alloimmune thrombocytopenia and neonatal alloimmune neutropenia as well as to the common themes in neonatal hematology.